Pfizer says COVID-19 pill cut hospital, death risk by nearly 90%
Shares of Indianapolis-based Eli Lilly and Co., which makes an antibody treatment for COVID-19 that requires infusions, were down 2.7% in late-morning trading Friday, to $263.76 each.
Shares of Indianapolis-based Eli Lilly and Co., which makes an antibody treatment for COVID-19 that requires infusions, were down 2.7% in late-morning trading Friday, to $263.76 each.
Republican governors or attorneys general in Alabama, Arizona, Arkansas, Florida, Idaho, Indiana, Iowa, Louisiana, Missouri, Montana, Nebraska, New Hampshire, Oklahoma and South Dakota said Thursday they would file lawsuits against the mandate.
Pushback from Indiana’s Republican-led government came just hours after the Democratic administration of President Joe Biden finalized rules for federal vaccine mandates that are set to be enforced starting Jan. 4.
The Indiana State Department of Health on Thursday reported 2,065 more cases of COVID-19, up from 2,024 cases the previous day.
Indiana Gov. Eric Holcomb issued a statement Thursday, saying he would challenge the federal order.
The Indiana State Department of Health said 59.6% of Indiana residents 18 and older are now fully vaccinated.
The decision marks the first opportunity for Americans under 12 to get the protection of any COVID-19 vaccine.
More than 3.37 million Hoosiers had been fully vaccinated against COVID-19 as of Tuesday after a daily increase of almost 1,700.
The purchase will amount to 614,000 doses of two drugs, bamlanivimab and etesevimab, that make up the drug-cocktail infusion, Lilly said.
Anticipating a green light from vaccine advisers, the Biden administration is assembling and shipping millions of COVID-19 shots for children ages 5-11, the White House said Monday. The first could go into arms by midweek.
Statewide hospitalizations due to COVID-19 ticked up from 1,284 on Saturday to 1,297 on Sunday. Saturday’s number was the lowest since Aug. 8.
U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.
Breakthrough cases of COVID-19—when a fully vaccinated person tests positive for the virus—make up a low ratio of COVID cases in Indiana, but they aren’t extremely rare.
Indiana officials said Wednesday that the state should be able to immediately inoculate a third of children ages 5 to 11 if the federal government gives approval to vaccines for that age group.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
The cumulative total of deaths during the pandemic officially rose to 16,022, the department said Tuesday. Another 545 probable deaths due to COVID also have been reported.
An influential COVID-19 forecasting model is predicting increasing infections and hospitalizations in November. Also, COVID deaths per day have begun to creep back up again after a decline that started in late September.
Statewide hospitalizations due to COVID-19 have dropped 32% since the beginning of the month and 51% since hitting a recent peak of 2,687 on Sept. 13.
Gov. Eric Holcomb is asking the state’s high court to review a judge’s ruling that upheld a new law giving legislators more power to intervene during public health emergencies.
Details of Pfizer’s study were posted online. The Food and Drug Administration was expected to post its independent review of the company’s safety and effectiveness data later in the day on Friday.